COX-2 expression in oral lichen planus

Dermatology

Volumn 217, Issue 2, 2008, Pages 150-155

  Lysitsa, Stella ^a,c   Samson, Jacky ^a   Gerber Wicht, Christine ^b   Lang, Ursula ^b   Lombardi, Tommaso ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c Division of Stomatology and Oral Surgery   (Switzerland)

Author keywords

Cyclooxygenase 2; Oral lichen planus; Precursor lesions; Squamous cell carcinoma

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADULT; ARTICLE; ATROPHIC SKIN DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MALE; MALIGNANT TRANSFORMATION; MOUTH LICHEN PLANUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COHORT STUDIES; CYCLOOXYGENASE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 49649122019     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137672     Document Type: Article

References (41)

1. Scully C, Beyli M, Ferreiro MC, et al: Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9:86-122.
2. Lodi G, Scully C, Carozzo M, Griffiths M, Sugerman P, Thongprasom K: Current controversies in oral lichen planus: report of an international consensus meeting. 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:40-51.
3. Mignogna MD, Fedele S, Russo L, Muzio L, Bucci E: Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004;40:120-130.
4. Sugerman PB, Savage NW, Walsh LJ, et al: The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13:350-365.
5. Andreansen JO: Oral lichen planus: a clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25:31-42.
6. Karatsaidis A, Schreurs O, Helgeland K, Axell T, Schenck K: Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J Oral Pathol Med 2003;32:275-281.
7. Kuffer R, Samson J, Lombardi T: Cicatricial states of oral lichen planus: the role of post lichen state. J Oral Pathol Med 2002;31:289-314.
8. Kuffer R, Lombardi T: Erosion and ulceration occurring on oral lichen planus. Dermatology 2003;207:340.
9. Brajac I, Loncarek K, Kastelan M, Manestar-Blazic T: Fractal formation of lichen planus. Dermatology 2007;215:269-270.
10. Chandrasekharan NV, Dai H, Roos KL, et al: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-13931.
11. Mohan S, Epstein JB: Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol 2003;39:537-546.
12. Itoh S, Matsui K, Furuta I, Takano Y: Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol 2003;39:829-835.
13. Shibata M, Kodani I, Osaki M, et al: Cyclooxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 2005;41:304-312.
14. Sudbo J, Ristimäki A, Sondresen JE, et al: Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol 2003;39:497-505.
15. Chan G, Boyle JO, Yang EK, et al: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-994.
16. Stolina M, Sharma S, Lin Y, et al: Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361-370.
17. Barnard NA, Scully C, Eveson JW, Cunningham S, Porter SR: Oral cancer development in patients with oral lichen planus. J Oral Pathol Med 1993;22:421-424.
18. Hietanen J, Paasonen MR, Kuhlefelt M, Malmström M: A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. Oral Oncol 1999;35:278-282.
19. van der Meij EH, Schepman KP, van der Waal I: The possible premalignant character of oral lichen planus and lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:164-171.
20. Eisenberg E: Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000;58:1278-1285.
21. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP: Molecular analysis of oral lichen planus: a premalignant lesion? Am J Pathol 1997;151:323-327.
22. Axell T, Rundquist L: Oral lichen planus: a demographic study. Community Dent Oral Epidemiol 1987;15:52-56.
23. Mattsson U, Jontell M, Holmstrup P: Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med 2002;135:390-396.
24. Neppelberg E, Johannessen AC: DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol 2007;264:1223-1230.
25. Moraitis D, Baoheng D, Lorenzo M, et al: Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res 2005;2:664-670.
26. Charles EE, Robert JC, Alamandla R, Francis MG, Suzanne F, Raymond D: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-1188.
27. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58:4997-5001.
28. Boldrup L, Coates PJ, Hedberg Y, Sjostrom B, Dahlgvist A, Nylander K: Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. Int J Oncol 2005;27:1661-1667.
29. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K: Current controversies in oral lichen planus: report of an international consensus meeting. 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:164-178.
30. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN: Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 2006;38:1654-1661.
31. Holmstrup P, Pindborg JJ: Erythroplakic lesions in relation to oral lichen planus. Acta Derm Venereol Suppl (Stockh) 1979;59:77-84.
32. Shamma A, Yamamoto H, Doki Y, et al: Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000;6:1229-1238.
33. Nathan CA, Leskov IL, Lin M, et al: COX-2 expression in dysplasia of the head and neck: correlation with elF4E. Cancer 2001;92:1888-1895.
34. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK: Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-1271.
35. Yamamoto K, Kitayama W, Denda A, Morisaki A, Kuniyasu H, Kirita T: Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide. Cancer Lett 2003;199:121-129.
36. Ratnasinghe D, Tangrea J, Roth MJ, et al: Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus: an immunohistochemical survey. Anticancer Res 1999;19:171-174.
37. Lee DW, Sung MW, Park SW, et al: Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 2002;22:2089-2096.
38. Renkonen J, Wolff H, Paavonen T: Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch 2002;440:594-597.
39. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002;62:625-631.
40. Feng L, Wang Z: Chemopreventive effect of celecoxib in prevention of oral pre-cancers and cancers. Laryngoscope 2006;116: 1842-1845.
41. Akita Y, Kozaki K, Nakagawa A, et al: Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity. Br J Dermatol 2004;151:472-480.